ESMO Open

Published by Elsevier

Open access · CC BY-NC-ND · In DOAJ · Kingdom of the Netherlands · Cancer Immunotherapy and Biomarkers

Journal at a glance

ISSN

2059-7029

Publisher

Elsevier

Country

Kingdom of the Netherlands

Language

en

License

CC BY-NC-ND

Also known as: ESMO open cancer horizons (Alternate title), European Society for Medical Oncology open (Alternate title)

Indexing

• Web of Science (SCIE): Indexed
• Scopus: Indexed
• DOAJ: Active
• Medline: Active
• Pubmed: Active

Metrics

Subjects

• Cancer Immunotherapy and Biomarkers
• Lung Cancer Treatments and Mutations
• Advanced Breast Cancer Therapies
• Breast Cancer Treatment Studies
• HER2/EGFR in Cancer Research
• Cancer Genomics and Diagnostics
• Cancer Treatment and Pharmacology
• Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
• Internal medicine

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer (2026)
• HER1–HER4 expression and co-expression in advanced urothelial carcinoma (2026)
• MYC rearrangement improves the predictive efficacy of the double-hit model in newly diagnosed multiple myeloma (2026)
• Final analysis of the FeDeriCa phase III study: long-term efficacy, safety and pharmacokinetics of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection, plus chemotherapy, in HER2-positive early breast cancer (2026)
• Ultrasensitive circulating tumor DNA detection improves prognostication in triple-negative breast cancer postneoadjuvant therapy (2026)

Similar journals

• Oncologist — United Kingdom · Open access · Same subject: Breast Cancer Treatment Studies, Same subject: Cancer Genomics and Diagnostics, 6 shared subjects in total
• Breast Cancer: Targets and Therapy — New Zealand · Open access · Same subject: Advanced Breast Cancer Therapies, Same subject: Breast Cancer Treatment Studies, 4 shared subjects in total, Same language
• Future Oncology — United Kingdom · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total
• JAMA Oncology — United States · — · Same subject: Breast Cancer Treatment Studies, Same subject: Cancer Genomics and Diagnostics, 4 shared subjects in total
• American Society of Clinical Oncology Educational Book — United States · — · Same subject: Breast Cancer Treatment Studies, Same subject: Cancer Genomics and Diagnostics, 4 shared subjects in total
• Investigational New Drugs — Kingdom of the Netherlands · — · Same subject: Cancer Treatment and Pharmacology, Same subject: HER2/EGFR in Cancer Research, 3 shared subjects in total, Same country

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref, Web of Science (Clarivate), Scopus · Last verified 2026-09-05

Journal homepage · Author guidelines